Close Menu
Home » OpGen Raises $17M to Market Optical Mapping System

OpGen Raises $17M to Market Optical Mapping System

Sep 28, 2010
Premium

This story was originally published Sept. 27

OpGen, a commercial provider of optical restriction-mapping technology, has raised $17 million in Series B financing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Letter Condemns Virus Conspiracy Theories

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

Philip Leder Dies

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

New and Maybe Important

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

Nucleic Acids Research Studies on Alu Genotyping, Stress Response Histones, Undocumented Small RNAs

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.

What's Popular?

In Clinical Sequencing

  1. Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.